The Bredesen Protocol

I am proud to be a Certified ReCODE 2.0 Coach through Apollo Health.

Bredesen Seven
Neuroplasticity is at the Core of the Bredesen Protocol

Optimizing the brains ‘neuroplasticity’ is the basis of the Bredesen protocol. Think of Neuroplasticity as the brain’s ability to be quickly responsive, adaptable and flexible to its biochemical environment based on our whole-body ecosystem …. And based on how we’ve cared for ourselves over the years.

The Bredesen Protocol – for Prevention (PreCODE) + Reversal (ReCode)

The Bredesen Protocol is based on over three decades of Dr. Dale Bredesen’s laboratory research, resulting in hundreds of peer-reviewed publications that have uncovered the biochemical mechanisms behind the erosion of memory associated with Alzheimer’s disease. The Bredesen Protocol offered through PreCODE (for prevention) and ReCODE (for reversal) has opened the door to new approaches to prevent and treat Alzheimer’s disease.

Dr. Bredesen has identified over 36 factors (metabolic derangement, poor nutrient status, lack of trophic support, exposure to viruses, etc.) that act like 36 leaky holes in a roof.

These ‘leaky energy holes’ can trigger “downsizing” in the brain, all of which can be addressed by using the Bredesen Protocol designed to prevent cognitive decline and reverse the effects of subjective cognitive impairment (SCI), mild cognitive impairment (MCI), and early Alzheimer’s disease.

Check out these Clinical Trial Articles
clinical trials

Reversal of cognitive decline: A novel therapeutic program

Copyright: © 2022 Bredesen et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Precision Medicine Approach to Alzheimer’s Disease: Successful Pilot Project

Toups K, Hathaway A, Gordon D, Chung H, Raji C, Boyd A, Hill BD, Hausman-Cohen S, Attarha M, Chwa WJ, Jarrett M, Bredesen DE. Precision Medicine Approach to Alzheimer’s Disease: Successful Pilot Project. J Alzheimers Dis. 2022;88(4):1411-1421. doi: 10.3233/JAD-215707. PMID: 35811518; PMCID: PMC9484109.